| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/15/2022 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (right to buy) | 20.3k | $1.62 | $32.9k | | 09/15/2022 |
| 05/18/2022 | Evolus, Inc. | EOLS | Sale | Common Stock | 52k | $12.42 | $646k | | 05/17/2022 |
| 05/17/2022 | Evolus, Inc. | EOLS | Sale | Common Stock | 16.2k | $13.92 | $225.4k | | 05/17/2022 |
| 03/08/2022 | Evolus, Inc. | EOLS | Sale | Common Stock | 10.2k | $9.73 | $99.1k | | 03/08/2022 |
| 01/24/2022 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 77.6k | $5.46 | $423.9k | | 01/24/2022 |
| 01/24/2022 | Evolus, Inc. | EOLS | Grant | Common Stock | 53.6k | $0.00 | $0 | | 01/24/2022 |
| 08/10/2021 | Evolus, Inc. | EOLS | Sale | Common Stock | 14.3k | $11.18 | $159.8k | | 08/10/2021 |
| 08/10/2021 | Evolus, Inc. | EOLS | Sale | Common Stock | 14.3k | $11.18 | $159.8k | | 08/10/2021 |
| 01/27/2021 | Evolus, Inc. | EOLS | Grant | Common Stock | 90k | $0.00 | $0 | | 01/27/2021 |
| 01/25/2021 | Evolus, Inc. | EOLS | Sale | Common Stock | 2.7k | $7.46 | $20.1k | | 01/25/2021 |
| 05/13/2020 | Evolus, Inc. | EOLS | Grant | Common Stock | 40k | $0.00 | $0 | | 05/13/2020 |
| 01/23/2020 | Evolus, Inc. | EOLS | Grant | Common Stock | 26k | $0.00 | $0 | | 01/23/2020 |
| 01/23/2020 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 45k | $10.19 | $458.6k | | 01/23/2020 |
| 05/31/2019 | Evolus, Inc. | EOLS | Sale | Common Stock | 2.6k | $13.53 | $35.4k | | 05/31/2019 |
| 01/23/2019 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 45k | $16.19 | $728.6k | | 01/23/2019 |
| 05/29/2018 | Evolus, Inc. | EOLS | Grant | Common Stock | 30k | $0.00 | $0 | | 05/29/2018 |
| 05/29/2018 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 200k | $22.44 | $4.5M | | 05/29/2018 |
| 05/22/2018 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 2.9k | $30.25 | $86.9k | | 05/22/2018 |
| 03/22/2018 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 3.4k | $30.85 | $105.8k | | 03/22/2018 |
| 03/15/2018 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 1.2k | $31.65 | $36.5k | | 03/13/2018 |
| 03/13/2018 | Revance Therapeutics, Inc. | RVNC | Exercise | Stock Option (Right to buy) | 25.9k | $8.70 | $225k | | 03/13/2018 |
| 03/13/2018 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 25.9k | $34.50 | $892.4k | | 03/13/2018 |
| 03/09/2018 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 10k | $32.50 | $325k | | 03/07/2018 |
| 03/09/2018 | Revance Therapeutics, Inc. | RVNC | Exercise | Stock Option (Right to buy) | 10k | $8.70 | $87k | | 03/07/2018 |
| 03/07/2018 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 10k | $31.50 | $315k | | 03/07/2018 |
| 03/07/2018 | Revance Therapeutics, Inc. | RVNC | Exercise | Stock Option (Right to buy) | 10k | $8.70 | $87k | | 03/07/2018 |
| 02/15/2018 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 1.1k | $31.75 | $36.1k | | 02/15/2018 |
| 02/08/2018 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 8.1k | $0.00 | $0 | | 02/08/2018 |
| 02/08/2018 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 48.8k | $29.15 | $1.4M | | 02/08/2018 |
| 01/28/2018 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 990 | $33.50 | $33.2k | | 01/28/2018 |
| 12/29/2017 | Revance Therapeutics, Inc. | RVNC | Other (acquisition) | Common Stock | 443 | $22.99 | $10.2k | | 12/29/2017 |
| 12/26/2017 | Revance Therapeutics, Inc. | RVNC | Exercise | Stock Option (Right to buy) | 17.5k | $8.70 | $152.3k | | 12/26/2017 |
| 11/07/2017 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 10k | $26.83 | $268.3k | | 11/07/2017 |
| 11/07/2017 | Revance Therapeutics, Inc. | RVNC | Exercise | Stock Option (Right to Buy) | 10k | $8.70 | $87k | | 11/07/2017 |
| 10/12/2017 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 11.2k | $26.67 | $297.8k | | 10/12/2017 |
|